Review Article: Advanced Bladder Cancer: The Need to Identify New Agents in the Post-M-VAC (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) World-Reference-Cited by-同舟云学术

Review Article: Advanced Bladder Cancer: The Need to Identify New Agents in the Post-M-VAC (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) World

Published:1995-03 Issue:3S Volume:153 Page:894-900
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Roth Bruce J.¹,Bajorin Dean F.¹

Affiliation:

1. From the Indiana University Cancer Center, Department of Medicine, Division of Hematology/Oncology, Indiana University Medical Center, Indianapolis, Indiana, Department of Medicine, Division of Solid Tumor Oncology, Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center and Department of Medicine, Cornell University Medical Center, New York, New York

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Doxorubicin Embedded into Nanofibrillated Bacterial Cellulose (NFBC) Produces a Promising Therapeutic Outcome for Peritoneally Metastatic Gastric Cancer in Mice Models via Intraperitoneal Direct Injection;Nanomaterials;2021-06-28

2. A Comprehensive Review of US FDA-Approved Immune Checkpoint Inhibitors in Urothelial Carcinoma;Journal of Immunology Research;2017

3. Chemotherapy in Advanced Urothelial Carcinoma;The Korean Journal of Urological Oncology;2016-08-30

4. Emerging concepts on drug resistance in bladder cancer: Implications for future strategies;Critical Reviews in Oncology/Hematology;2015-10

5. Prognostic and predictive factors in patients treated with chemotherapy for advanced urothelial cancer: where do we stand?;Future Oncology;2015-01